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We employed X-irradiation to activate a caged amino acid with a 2-oxoalkyl group. We 
designed and synthesized tyrosine derivative caged by a 2-oxoalkyl group (Tyr(Oxo)) to 
evaluate its radiolytic one-electron reduction characteristics in aqueous solution. Upon 
hypoxic X-irradiation, Tyr(Oxo) released a 2-oxopropyl group to form the 
corresponding uncaged tyrosine. In addition, radiolysis of dipeptides containing 
Tyr(Oxo) revealed that the efficiency of radiolytic removal of 2-oxopropyl group 
increased significantly by the presence of neighboring aromatic amino acids. 
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Caged amino acids and proteins, the functions of which can be regulated by external 
triggers, are applied widely to biological research.1-5 The activities of these molecules 
can be blocked by chemical modification, while their intrinsic activities are recovered 
by external stimulation such as photoirradiation6 and enzymatic treatment.4 In view of a 
feature that their functions are easily regulated both temporally and spatially, these 
caged amino acids are useful for studying protein chemistry in biological systems.   
Recently we have proposed caged drugs (prodrugs) that are activated by hypoxic 
X-irradiation.7-11 Our studies illustrated that a 2-oxoalkyl group has an effective 
functionality for caging antitumor drugs such as 5-fluorouracil (5-FU)8,9 and 
5-fluorodeoxyuridine (5-FdUrd),10 and for radiolytic activation of the resultant caged 
drugs. This class of radiation activated caged drugs release the 2-oxoalkyl group by 
reducing hydrated electrons, which are generated as the major active species along with 
hydrogen atoms and hydroxyl radicals upon radiolysis of an aqueous solution. An 
activation mechanism has been proposed by which the 2-oxoalkyl group undergoes 
one-electron reduction by hydrated electrons to form corresponding π* anion radical, 
followed by thermal activation into the σ* anion radical that has a weakened N-C bond 
between the 5-FU unit and the 2-oxoalkyl group and is readily hydrolyzed to release the 
2-oxoalkyl group. In this study, we designed and synthesized an amino acid caged by a 
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2-oxopropyl group on tyrosine (Tyr), which has a high affinity for hydrated electrons.12 
Under hypoxic conditions, radiolytic one-electron reduction of tyrosine derivative 
possessing 2-oxopropyl group (Tyr(Oxo)) resulted exclusively in releasing of 
2-oxopropyl group to recover the corresponding uncaged Tyr. In the case of dipeptides 
bearing Tyr(Oxo), the neighboring amino acid was identified to have a strong influence 
on the overall efficiency of radiolytic one-electron reductive release of the 2-oxopropyl 
group from Tyr(Oxo). 
 
The synthetic procedure of Tyr(Oxo) is outlined in Scheme 1. Coupling of 
N-(tert-butoxycarbonyl)tyrosine methyl ester 1 with α-bromoacetone and deprotection 




We initially performed one-electron reduction of Tyr(Oxo) by the X-radiolysis of an 
argon-purged aqueous solution containing excess 2-methyl-2-propanol as the scavenger 
of oxidizing hydroxyl radicals.14 Reducing hydrate electrons (eaq–) are generated as the 
major active species under these radiolysis conditions, in which the yield of reducing 
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hydrogen atoms is much less than those of hydrated electrons and oxidizing hydroxyl 
radicals.15 Figure 1 shows the reaction profiles of the radiolytic reduction of Tyr(Oxo) 
under hypoxic conditions. The appearance of a single new peak in Figure 1 is 
attributable to the formation of uncaged Tyr as confirmed by the overlap injection of 
authentic samples in the HPLC analysis. The G values (the number of molecules 
produced or changed per 1 J of radiation energy absorbed by the reaction system) were 
223 nmol/J for the decomposition of caged Tyr(Oxo) and 130 nmol/J for the formation 
of the corresponding uncaged Tyr.16 These results clearly indicate that the 2-oxopropyl 




To assess the effect of molecular oxygen on the radiolysis of Tyr(Oxo), we performed 
similar one-electron reduction under aerobic conditions. In contrast to the hypoxic 
X-radiolysis, the removal of the 2-oxopropyl group to convert Tyr(Oxo) into Tyr 
became considerably less efficient in the aerobic X-radiolysis (Figure 2). The G values 
were estimated as 81 nmol/J for the decomposition of Tyr(Oxo) and 51 nmol/J for the 
formation of Tyr. In view of well-documented evidence that molecular oxygen 
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efficiently inhibits radiolytic reduction due to the trapping of eaq– to form a superoxide 
anion radical,17 the one-electron reduction of Tyr(Oxo) by eaq– is likely to occur in a 




To identify the effect of the neighboring amino acid on the radiolytic reduction of 
Tyr(Oxo), we compared one-electron reduction reactivity of dipeptides 7–13 comprising 
Tyr(Oxo) and seven types of natural amino acids upon hypoxic or aerobic X-irradiation. 
Dipeptides 7–13 were prepared from 3 (Ac-Tyr-OMe) as outlined in Scheme 2. The 
phenol group of 4 was alkylated by α-bromoacetone, and subsequent hydrolysis gave 
acid 6. Coupling of 6 with the corresponding amino acids furnished the synthesis of 
dipeptides 7–13.18 Figure 3 shows representative reaction profiles of the radiolytic 
reduction of dipeptide Tyr(Oxo)-Gly under hypoxic conditions. Similar to the radiolysis 
of monomeric Tyr(Oxo), reductive removal of the 2-oxopropyl group occurred 
commonly for all dipeptides in a hypoxia-selective manner. The dipeptides 10–13, in 
which Tyr(Oxo) is linked to aromatic amino acids, showed higher G values than 
dipeptides 7–9 with a linkage between Tyr(Oxo) and aliphatic amino acids, as listed in 
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Table 1. Thus, the neighboring amino acid has a marked effect on the one-electron 
reduction of Tyr(Oxo) to generate uncaged Tyr. It has been reported that aromatic amino 
acids are reduced by eaq– faster than aliphatic amino acids.12 These reduction 
characteristics of eaq– could be responsible for the accelerated reduction of dipeptides 
bearing aromatic amino acids. It is most likely that capturing of eaq– by the aromatic 
amino acid residues in the caged dipeptides occurred more efficiently followed by rapid 
intramolecular electron transfer to Tyr(Oxo), thereby resulting in the efficient formation 






In summary, we have demonstrated the activation of caged Tyr possessing a 2-oxoalkyl 
group by X-radiolytic one-electron reduction. Hypoxic X-irradiation caused the efficient 
removal of the 2-oxopropyl group on Tyr(Oxo), whereas the reaction efficiency 
decreased dramatically upon aerobic irradiation. More remarkable was that the 
neighboring aromatic amino acids increased the radiolytic reduction efficiency of 
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Tyr(Oxo), presumably due to their higher electron affinity. These results strongly 
indicate that functions of amino acids and proteins may be regulated by means of 
radiolytic reduction of 2-oxoalkyl group. Further exploration of the one-electron 
reduction of longer and higher-order peptides bearing Tyr(Oxo) by X-radiolysis is in 
progress.    
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aReagents and conditions: (a) K2CO3, KI, bromoacetone, acetone, reflux, quant.; (b) 
HCl in Et2O, room temperature, 78%. 
 
Scheme 2a 
aReagents and conditions: (a) K2CO3, KI, bromoacetone, acetone, reflux, 77%; (b) 
LiOH, MeOH-H2O, room temperature, 76%; (c) aminoacid methyl ester hydrochloride, 
HBTU, DIEA, THF, room temperature, 7-34% (for 7-12); (d) 1-methylhistidine methyl 
ester hydrochloride, EDCI, triethylamine, DMF, room temperature, 28% (for 13). 
 
Figure 1. HPLC profiles for the one-electron reduction of Tyr(Oxo) (3) (95 μM) upon 
hypoxic X-radiolysis (0, 150, 400 and 700 Gy) of aqueous solution containing 10 mM 
2-methyl-2-propanol. 
 
Figure 2. Decomposition of Tyr(Oxo) (3) (open symbol) and release of Tyr (filled 
symbol) in the hypoxic (circle) or aerobic (triangle) radiolysis of aqueous solution 
containing 10 mM 2-methyl-2-propanol. Each error bar represents the SE calculated 
from three experimental results. 
 
Figure 3. HPLC profiles for the one-electron reduction of Tyr(Oxo)-Gly (7) (100 μM) 




 aReagents and conditions: (a) K2CO3, KI, bromoacetone, acetone, reflux, quant.; (b) 




aReagents and conditions: (a) K2CO3, KI, bromoacetone, acetone, reflux, 77%; (b) 
LiOH, MeOH-H2O, room temperature, 76%; (c) aminoacid methyl ester hydrochloride, 
HBTU, DIEA, THF, room temperature, 7-34% (for 7-12); (d) 1-methylhistidine methyl 
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Figure 2. Decomposition of Tyr(Oxo) (3) (open symbol) and release of Tyr (filled 
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Table 1.  G-values (nmol/J) for the Decomposition of Tyr(Oxo) (3) and Dipeptides 
Bearing Tyr(Oxo) and the Formation of Corresponding Uncaged Tyr and Dipeptides 
upon X-radiolysis.a 
 Hypoxic Conditions Aerobic Conditions 











Tyr(Oxo)-Ala(8) 96 232 20 72 
Tyr(Oxo)-Val(9) 72 209 18 83 
Tyr(Oxo)-Phe(10) 155 299 30 45 











a Aqueous solution of Tyr(Oxo) (3) and dipeptides (95-320 μM) containing excess 
amount of 2-methyl-2-propanol19 were irradiated at ambient temperature with X-ray 
source (5 Gy min-1). 
 
 
 
